FUNDED JUNE 2022
Techboard's monthly roundup logs June 2022 Australian funding events, including GO1's Series E, Edrolo's Series B, two acquisitions, several new funds reaching closes, and accelerator intake announcements.
Also Techboard
Startup · $850k raised
Melbourne, VIC
Every investor coverage indicates participated in a round Cleer raised.
| Investor | Rounds | Invested |
|---|---|---|
| Birchal | Unnamed stage | - |
| VentureCrowd | Pre-seed | $650,000 |
Companies Cleer acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Leo de Bruijn | CEO and Managing Director | Startup Daily |
| Leo de Bruin | Co-founder and Chief | SmartCompany, Startup Daily (Mon 2 Nov 2020), Startup Daily (Wed 23 Sep 2020) |
| Professor Andrew Coats | Chairman | Startup Daily |
Stories naming Cleer. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Techboard's monthly roundup logs June 2022 Australian funding events, including GO1's Series E, Edrolo's Series B, two acquisitions, several new funds reaching closes, and accelerator intake announcements.
Also Techboard
A weekly roundup of Australian startup funding: Neara, Archistar, Urban Ethos, ESN Cleer and Book An Artist raise, alongside Mr Yum and Octopus Deploy raises.
Also Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany
Cut Through Venture's debut quarterly newsletter rounds up Q1 2021 raises across Australian and New Zealand startups, highlighting crowdfunding, fintech dominance, active investors, and two newly launched startups currently seeking backers.
Melbourne medtech firm ESN Cleer, developer of a saliva test for early heart-failure risk, is crowdfunding a pre-seed round on Birchal, having passed its minimum with over $120,000 pledged toward a $500,000 cap.
Melbourne medical technology firm ESN Cleer has opened a $2.4 million crowdfunding campaign on Birchal to fund the launch of its saliva-based screening test for early heart disease risk.